OBJECTIVE: This study was undertaken to better understand the high variability in response seen when treating human subjects with restorative therapies poststroke. Preclinical studies suggest that neural function, neural injury, and clinical status each influence treatment gains; therefore, the current study hypothesized that a multivariate approach incorporating these 3 measures would have the greatest predictive value. METHODS: Patients 3 to 6 months poststroke underwent a battery of assessments before receiving 3 weeks of standardized upper extremity robotic therapy. Candidate predictors included measures of brain injury (including to gray and white matter), neural function (cortical function and cortical connectivity), and clinical status (demographics/medical history, cognitive/mood, and impairment). RESULTS: Among all 29 patients, predictors of treatment gains identified measures of brain injury (smaller corticospinal tract [CST] injury), cortical function (greater ipsilesional motor cortex [M1] activation), and cortical connectivity (greater interhemispheric M1-M1 connectivity). Multivariate modeling found that best prediction was achieved using both CST injury and M1-M1 connectivity (r(2) = 0.44, p = 0.002), a result confirmed using Lasso regression. A threshold was defined whereby no subject with >63% CST injury achieved clinically significant gains. Results differed according to stroke subtype; gains in patients with lacunar stroke were best predicted by a measure of intrahemispheric connectivity. INTERPRETATION: Response to a restorative therapy after stroke is best predicted by a model that includes measures of both neural injury and function. Neuroimaging measures were the best predictors and may have an ascendant role in clinical decision making for poststroke rehabilitation, which remains largely reliant on behavioral assessments. Results differed across stroke subtypes, suggesting the utility of lesion-specific strategies.
OBJECTIVE: This study was undertaken to better understand the high variability in response seen when treating human subjects with restorative therapies poststroke. Preclinical studies suggest that neural function, neural injury, and clinical status each influence treatment gains; therefore, the current study hypothesized that a multivariate approach incorporating these 3 measures would have the greatest predictive value. METHODS:Patients 3 to 6 months poststroke underwent a battery of assessments before receiving 3 weeks of standardized upper extremity robotic therapy. Candidate predictors included measures of brain injury (including to gray and white matter), neural function (cortical function and cortical connectivity), and clinical status (demographics/medical history, cognitive/mood, and impairment). RESULTS: Among all 29 patients, predictors of treatment gains identified measures of brain injury (smaller corticospinal tract [CST] injury), cortical function (greater ipsilesional motor cortex [M1] activation), and cortical connectivity (greater interhemispheric M1-M1 connectivity). Multivariate modeling found that best prediction was achieved using both CST injury and M1-M1 connectivity (r(2) = 0.44, p = 0.002), a result confirmed using Lasso regression. A threshold was defined whereby no subject with >63% CST injury achieved clinically significant gains. Results differed according to stroke subtype; gains in patients with lacunar stroke were best predicted by a measure of intrahemispheric connectivity. INTERPRETATION: Response to a restorative therapy after stroke is best predicted by a model that includes measures of both neural injury and function. Neuroimaging measures were the best predictors and may have an ascendant role in clinical decision making for poststroke rehabilitation, which remains largely reliant on behavioral assessments. Results differed across stroke subtypes, suggesting the utility of lesion-specific strategies.
Authors: Cathy M Stinear; P Alan Barber; Peter R Smale; James P Coxon; Melanie K Fleming; Winston D Byblow Journal: Brain Date: 2007-01 Impact factor: 13.501
Authors: Steven C Cramer; Camille Fitzpatrick; Michael Warren; Michael D Hill; David Brown; Laura Whitaker; Karla J Ryckborst; Lawrence Plon Journal: Stroke Date: 2010-03-04 Impact factor: 7.914
Authors: Christian Grefkes; Dennis A Nowak; Ling E Wang; Manuel Dafotakis; Simon B Eickhoff; Gereon R Fink Journal: Neuroimage Date: 2009-12-18 Impact factor: 6.556
Authors: Vishwanath Sankarasubramanian; Andre G Machado; Adriana B Conforto; Kelsey A Potter-Baker; David A Cunningham; Nicole M Varnerin; Xiaofeng Wang; Ken Sakaie; Ela B Plow Journal: Clin Neurophysiol Date: 2017-03-21 Impact factor: 3.708
Authors: David S Liebeskind; Gregory W Albers; Karen Crawford; Colin P Derdeyn; Mark S George; Yuko Y Palesch; Arthur W Toga; Steven Warach; Wenle Zhao; Thomas G Brott; Ralph L Sacco; Pooja Khatri; Jeffrey L Saver; Steven C Cramer; Steven L Wolf; Joseph P Broderick; Max Wintermark Journal: Stroke Date: 2015-06-04 Impact factor: 7.914
Authors: Carmen M Cirstea; Phil Lee; Sorin C Craciunas; In-Young Choi; Joseph E Burris; Randolph J Nudo Journal: Am J Phys Med Rehabil Date: 2018-01 Impact factor: 2.159
Authors: David A Cunningham; Nicole Varnerin; Andre Machado; Corin Bonnett; Daniel Janini; Sarah Roelle; Kelsey Potter-Baker; Vishwanath Sankarasubramanian; Xiaofeng Wang; Guang Yue; Ela B Plow Journal: Restor Neurol Neurosci Date: 2015 Impact factor: 2.406
Authors: Jessica M Cassidy; Anirudh Wodeyar; Jennifer Wu; Kiranjot Kaur; Ashley K Masuda; Ramesh Srinivasan; Steven C Cramer Journal: Stroke Date: 2020-04-17 Impact factor: 7.914